Bebangco, Baby Girl .

HRN: 28-09-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/13/2025
11/20/2025
IV
120mg
Q6
T/C Omphalitis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: